Q4 2021 Holdings
Filed 2022-02-14 | 71 holdings | $631.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $182.7M | 521,643 | 28.9% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $150.3M | 1,885,850 | 23.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $83.7M | 2,165,586 | 13.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $65.9M | 8,031,094 | 10.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $37.1M | 3,228,917 | 5.9% |
| Centene Corp del(CNC) | COM | 15135B101 | $29.8M | 361,139 | 4.7% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $19.2M | 1,325,139 | 3.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $16.8M | 782,097 | 2.7% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $14.8M | 725,000 | 2.4% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $13.9M | 1,920,960 | 2.2% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $8.1M | 672,411 | 1.3% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $3.0M | 717,244 | 0.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $2.6M | 696,377 | 0.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $758.1K | 12,957,222 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $262.4K | 22,716,086 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $247.0K | 19,808,234 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $179.9K | 2,057,178 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $164.3K | 2,587,730 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $150.5K | 7,451,029 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $127.4K | 1,820,898 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $122.8K | 5,082,805 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $104.8K | 3,866,512 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $101.5K | 6,437,777 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $97.8K | 3,334,355 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $85.6K | 2,958,284 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $63.0K | 1,708,536 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $62.0K | 1,897,223 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $61.3K | 8,258,345 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $60.8K | 2,447,926 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $58.8K | 2,789,496 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $58.1K | 3,805,403 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $57.5K | 371,839 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $53.9K | 2,246,668 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $52.5K | 104,488 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $52.2K | 219,926 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $51.1K | 110,289 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $48.2K | 4,142,770 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $47.8K | 5,619,914 | 0.0% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $45.3K | 14,380,327 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $44.1K | 3,429,171 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $41.6K | 3,083,501 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $39.9K | 1,203,619 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $37.8K | 765,675 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $33.9K | 1,602,285 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $33.5K | 1,954,420 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $31.2K | 3,671,009 | 0.0% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $26.3K | 1,170,225 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $26.2K | 661,621 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $25.1K | 1,500,000 | 0.0% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $24.4K | 2,500,000 | 0.0% |